Disease | lung cancer |
Phenotype | C0011570|depression |
Sentences | 19 |
PubMedID- 22095232 | Several small- and medium-scale studies on this topic exist and have for example revealed particularly high levels of depression in patients with lung cancer (hopwood and stephens, 2000; néron et al, 2007; castelli et al, 2009), but comparison studies with sufficient statistical power to examine various potential predictor and moderator variables are scarce. |
PubMedID- 22383265 | depression in lung cancer patients: the role of perceived stigma. |
PubMedID- PMC3287701 | Smart oncology-3 is a 150 patient efficacy trial evaluating a similar intervention for depression in patients with lung cancer, who have limited life expectancy, with data collected over eight months to give an average depression score for the primary outcome. |
PubMedID- 23102652 | Treatment of depression in people with lung cancer: a systematic review. |
PubMedID- 23731354 | Our aim was to asses if dimensions of temperament and character could predict depression in lung cancer patients. |
PubMedID- 26273380 | Self-reported depression among patients with non-small cell lung cancer. |
PubMedID- 26516360 | Purpose: the current study examined quality of life, progression of disease, and survival rate during chemotherapy in newly diagnosed non-small cell lung cancer (nsclc) patients with depression (n=48) and without depression (n=78). |
PubMedID- 25316948 | depression in lung cancer patients. |
PubMedID- 25175097 | We aimed to assess the efficacy of an integrated treatment programme for major depression in patients with lung cancer compared with usual care. |
PubMedID- 22510506 | Conclusions: feiji decoction for soothing the liver combined with psychotherapy can alleviate depression and anxiety in patients with primary lung cancer. |
PubMedID- 25800229 | The impact of a multidimensional exercise intervention on physical and functional capacity, anxiety, and depression in patients with advanced-stage lung cancer undergoing chemotherapy. |
PubMedID- 23969030 | The diurnal rhythms of sputum il-6, sputum tnf-alpha and salivary cortisol were measured in lung cancer patients with and without depression as well as depressed controls and healthy controls. |
PubMedID- 23680580 | Methods: using a modified adapte process, panels of local experts adapted national guidelines and integrated research evidence to create computable algorithms with explicit recommendations for management of the most common symptoms (pain, fatigue, dyspnea, depression, and anxiety) associated with lung cancer. |
PubMedID- 22473594 | Background: various risk factors for depression in lung cancer patients have been suggested but have been examined separately in studies with relatively small sample sizes. |
PubMedID- 22876057 | Patients were defined as having a chronic disease (allergic rhinitis, arthritis, coronary heart disease, depression, gi ulcer, history of pulmonary tuberculosis, lung cancer, or osteoporosis) if they answered affirmatively to the question, "have you had [name of chronic disease] lasting 6 months or more that was diagnosed by a health professional?" |
PubMedID- 21807767 | In the present study, we explored the degree to which tumor genotype may be associated with depression in patients with non-small cell lung cancer (nsclc). |
PubMedID- 26360998 | The prevalence of major depression was highest in patients with lung cancer (13.1%, 95% ci 11.9-14.2%), followed by gynaecological cancer (10.9%, 9.8-12.1), breast cancer (9.3%, 8.7-10.0), colorectal cancer (7.0%, 6.1-8.0), and genitourinary cancer (5.6%, 4.5-6.7). |
PubMedID- 23794580 | Fatigue and ‘disabilities’ independently predicted depression among patients with lung cancer starting treatment26 and have been observed in prechemotherapy patients with curative cancer.27 a high-symptom burden can persist over time. |
PubMedID- 19199317 | Results: anxiety occurred in 40% and depression in 25% of these lung cancer patients, equally among inpatients and outpatients. |
Page: 1